176 related articles for article (PubMed ID: 24944648)
1. Triple-negative breast cancer frequency and type of
Palomba G; Budroni M; Olmeo N; Atzori F; Ionta MT; Pisano M; Tanda F; Cossu A; Palmieri G
Oncol Lett; 2014 Apr; 7(4):948-952. PubMed ID: 24944648
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
Comen E; Davids M; Kirchhoff T; Hudis C; Offit K; Robson M
Breast Cancer Res Treat; 2011 Aug; 129(1):185-90. PubMed ID: 21394499
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.
Wong-Brown MW; Meldrum CJ; Carpenter JE; Clarke CL; Narod SA; Jakubowska A; Rudnicka H; Lubinski J; Scott RJ
Breast Cancer Res Treat; 2015 Feb; 150(1):71-80. PubMed ID: 25682074
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
[TBL] [Abstract][Full Text] [Related]
5. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
[TBL] [Abstract][Full Text] [Related]
6. [BRCA1/2 gene mutation and clinicopathologic features of triple negative breast cancer].
Ma ZP; Wang W; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):397-400. PubMed ID: 27256048
[TBL] [Abstract][Full Text] [Related]
7. Association between basal-like phenotype and
Jung J; Kang E; Gwak JM; Seo AN; Park SY; Lee AS; Baek H; Chae S; Kim EK; Kim SW
Curr Oncol; 2016 Oct; 23(5):298-303. PubMed ID: 27803593
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients.
Seong MW; Kim KH; Chung IY; Kang E; Lee JW; Park SK; Lee MH; Lee JE; Noh DY; Son BH; Park HL; Cho SI; Park SS; ; Kim SW
Breast Cancer Res Treat; 2014 Jul; 146(1):63-9. PubMed ID: 24894343
[TBL] [Abstract][Full Text] [Related]
9. Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia.
Mahfoudh W; Bettaieb I; Ghedira R; Snoussi K; Bouzid N; Klayech Z; Gabbouj S; Remadi Y; Hassen E; Bouaouina N; Zakhama A
J Transl Med; 2019 Apr; 17(1):123. PubMed ID: 30975216
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
Engel C; Rhiem K; Hahnen E; Loibl S; Weber KE; Seiler S; Zachariae S; Hauke J; Wappenschmidt B; Waha A; Blümcke B; Kiechle M; Meindl A; Niederacher D; Bartram CR; Speiser D; Schlegelberger B; Arnold N; Wieacker P; Leinert E; Gehrig A; Briest S; Kast K; Riess O; Emons G; Weber BHF; Engel J; Schmutzler RK;
BMC Cancer; 2018 Mar; 18(1):265. PubMed ID: 29514593
[TBL] [Abstract][Full Text] [Related]
11. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.
Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M
Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642
[TBL] [Abstract][Full Text] [Related]
12. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
[TBL] [Abstract][Full Text] [Related]
13. A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.
Palomba G; Loi A; Uras A; Fancello P; Piras G; Gabbas A; Cossu A; Budroni M; Contu A; Tanda F; Farris A; Orrù S; Floris C; Pisano M; Lovicu M; Santona MC; Landriscina G; Crisponi L; Palmieri G; Monne M
BMC Cancer; 2009 Jul; 9():245. PubMed ID: 19619314
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors.
Hata C; Nakaoka H; Xiang Y; Wang D; Yang A; Liu D; Liu F; Zou Q; Wei L; Zheng K; Inoue I; You H
J Hum Genet; 2020 Jul; 65(7):577-587. PubMed ID: 32029870
[TBL] [Abstract][Full Text] [Related]
15. Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.
De Brakeleer S; De Grève J; Desmedt C; Joris S; Sotiriou C; Piccart M; Pauwels I; Teugels E
Clin Genet; 2016 Mar; 89(3):336-40. PubMed ID: 26010302
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Gonzalez-Angulo AM; Timms KM; Liu S; Chen H; Litton JK; Potter J; Lanchbury JS; Stemke-Hale K; Hennessy BT; Arun BK; Hortobagyi GN; Do KA; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2011 Mar; 17(5):1082-9. PubMed ID: 21233401
[TBL] [Abstract][Full Text] [Related]
17. Association Between
Chen H; Wu J; Zhang Z; Tang Y; Li X; Liu S; Cao S; Li X
Front Pharmacol; 2018; 9():909. PubMed ID: 30186165
[TBL] [Abstract][Full Text] [Related]
18. Genomic Profiling Comparison of Germline
Huang X; Shao D; Wu H; Zhu C; Guo D; Zhou Y; Chen C; Lin Y; Lu T; Zhao B; Wang C; Sun Q
Front Oncol; 2020; 10():583314. PubMed ID: 33194720
[No Abstract] [Full Text] [Related]
19. Effects of
Pogoda K; Niwińska A; Sarnowska E; Nowakowska D; Jagiełło-Gruszfeld A; Siedlecki J; Nowecki Z
J Oncol; 2020; 2020():8545643. PubMed ID: 32322271
[TBL] [Abstract][Full Text] [Related]
20. Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia.
Budroni M; Cesaraccio R; Coviello V; Sechi O; Pirino D; Cossu A; Tanda F; Pisano M; Palomba G; Palmieri G
BMC Cancer; 2009 Feb; 9():62. PubMed ID: 19232099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
